Connect the Dots

Work

Future jobs of FDA's haematology-oncology reviewers

Research letter by Jeffrey Bien and Vinay Prasad in The BMJ, 27 September 2016.

2 links, 0 backed by primary records

Play the story Explore connections

Dates
27 Sep 2016

Connections 2

author

Timeline 3 dates
  1. 27 Sep 2016 Future jobs of FDA's haematology-oncology reviewers
  2. 27 Sep 2016 Jeffrey Bien authored Future jobs of FDA's haematology-oncology reviewers
  3. 27 Sep 2016 Vinay Prasad authored Future jobs of FDA's haematology-oncology reviewers
Proof 1 source
  1. Future jobs of FDA's haematology-oncology reviewers, The BMJ, 27 Sep 2016. Scholarship & press Archived copy
    Jeffrey Bien , internal medicine resident 1 , Vinay Prasad , assistant professor of medicine 1
    We identified 55 unique haematology-oncology medical reviewers from 2001 to 2010.
    Some 27 (49%) continued to work exclusively at the FDA
    Of the 26 who left the FDA, 15 (57.7%) later worked for the biopharmaceutical industry or consulted to it.
    If anything, we underestimate the extent of this phenomenon, as not all reviewers’ future careers could be identified.
Page history 1 change
  1. Add 55 stories, each checked against its sourcesAlibek96e92fe6

Something wrong or missing? Tell us, with a source, or edit this page.